SVB Exposes ‘Lazy’ ESG Funds as Hundreds Bet on Doomed Bank

SVB Gave $74 Million to Black Lives Matter. It Explains a Lot About the Bank’s Collapse

SVB Doesn’t Deserve a Taxpayer Bailout

Sam Bankman-Fried Becomes an ESG Truth-Teller

The EEOC’s mission is opportunity for all, not demographic bean-counting 

In the Superman comics, Bizarro World is a place where everything is exactly backward. It is a cube-shaped planet where ugliness is admired, failure is celebrated, lies are preferred to truth, and the normal rules of logic are turned upside down. What is obviously true on Earth becomes false, and what is plainly false is treated as a self-evident fact.   Donna Brazile recently accused the Equal Employment Opportunity Commission of abandoning its purpose by proposing to end mandatory annual race-and-sex workforce reporting. Her argument reads like a dispatch from Bizarro World.  In truth, the commission’s July 21 Notice of Proposed Rulemaking to rescind the EEO-1 and related demographic reports is a long-overdue course correction that reorients the agency to the actual text and original intent of Title VII of the Civil Rights Act of 1964.  Title VII forbids discrimination against any individual based on race, color, religion, sex or national origin. It does not authorize the government to compel every covered employer, regardless of whether a single discrimination charge has been filed, to annually sort its workforce into racial and sex categories and submit the tallies to Washington. That regime, in place for decades, imposed nearly $275 million in annual compliance costs on employers and roughly …

What Your Company’s Pride Sponsorship Supports

Many Americans are asking why corporations continue to fund LGBTQ Pride events that include programming or vendors that most can agree are seen as inappropriate for children. At certain events, attendees may encounter nightclubs, alcohol brands, cannabis dispensaries, or drag performances that often contain sexually suggestive elements. Many families would not ordinarily choose to expose their children to these types of environments, leading some to question why such programming is viewed differently when presented under the banner of LGBTQ+ Pride or “inclusion.” Before sponsoring socially contentious events, companies should carefully consider how they want their brands to be perceived by consumers, shareholders, employees, and the broader public. While stakeholders may hold differing opinions on many social issues, protecting the well-being of children remains a widely shared concern. Corporate sponsorships communicate a company’s values and priorities, making it important to evaluate whether those partnerships support its long-term business objectives and appeal to a broad customer base rather than a narrow segment of the market. NYC Pride is sponsored by Target, which publicly committed in 2025 to stop sponsoring nonbusiness causes. The event includes Youth Pride, a program specifically designed for LGBTQIA+ youth, their families, and allies, with the stated goal of  “empower[ing] …

Companies Reviewing GLP-1 Coverage Should Also Review Transgender Healthcare Coverage 

According to reports earlier this month, Starbucks is ending GLP-1 coverage for its employees. Under its new healthcare plan, Starbucks will no longer cover prescription drugs used for weight loss, but it will continue to cover comprehensive transgender healthcare interventions, including reconstructive surgical procedures and puberty blockers, for covered dependents. Employers are pulling back on GLP-1 coverage largely for the same reason they are reconsidering other benefits: to adjust to rising healthcare costs. RxBenefits reports that GLP-1 drugs cost roughly $1,000–$1,500 per month, while SHRM estimates employers often shoulder 70–100% of prescription drug costs.  With GLP-1s now accounting for around 20% of prescription drug spending and the number of users accelerating, employers face a limited set of choices: tighten eligibility requirements, shift more of the cost to employees or customers, or eliminate coverage altogether.  If companies can reasonably reconsider GLP-1 coverage because of cost, uncertain return on investment, and broader questions over what an employer-sponsored health plan should cover, why should other expensive medical benefits, such as transgender medical interventions, be exempt from similar scrutiny?  According to February 2026 data from the Human Rights Campaign, more than 550 major companies, including Starbucks, offer comprehensive transgender healthcare benefits to employees and covered dependents. While …